The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; 37 of the 64 sources its claims cite were checked for support.
Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence
Open accessAbstract
The expression of oncogenic ras in normal human cells quickly induces an aberrant proliferation response that later is curtailed by a cell cycle arrest known as cellular senescence. Here, we show that cells expressing oncogenic ras display an increase in the mitochondrial mass, the mitochondrial DNA, and the mitochondrial production of reactive oxygen species (ROS) prior to the senescent cell cycle arrest. By the time the cells entered senescence, dysfunctional mitochondria accumulated around the nucleus. The mitochondrial dysfunction was accompanied by oxidative DNA damage, a drop in ATP levels, and the activation of AMPK. The increase in mitochondrial mass and ROS in response to oncogenic ras depended on intact p53 and Rb tumor suppression pathways. In addition, direct interference with mitochondrial functions by inhibiting the expression of the Rieske iron sulfur protein of complex III or the use of pharmacological inhibitors of the electron transport chain and oxidative phosphorylation was sufficient to trigger senescence. Taking these results together, this work suggests that mitochondrial dysfunction is an effector pathway of oncogene-induced senescence.
Overview
CoChat Summary
TL;DR
Oncogenic Ras expression in normal human IMR90 fibroblasts increases mitochondrial mass, mtDNA, and mitochondrial ROS before senescence, then leads to depolarized perinuclear mitochondria, oxidative DNA damage, ATP loss, and AMPK activation. These mitochondrial changes require p53 or Rb, and direct mitochondrial interference by RISP knockdown or rotenone/oligomycin is sufficient to trigger senescence, suggesting mitochondrial dysfunction is an effector pathway of oncogene-induced senescence.
Key findings
- RasV12 induced mitochondrial superoxide by day 2 after selection and higher levels by day 8; mtDNA increased after day 2, and mitochondrial biogenesis genes NRF2a, PGC1α, PGC1β, and TFAM were induced before senescence, with NRF1 increased later.
- By senescence at day 8, Ras-expressing cells showed perinuclear depolarized mitochondria by JC-1, H2O2 accumulation, 8-OHdG oxidative DNA damage, SOD2/catalase induction by day 6, decreased ATP equivalent to oligomycin treatment, active AMPK, and higher glucose consumption than controls.
- p53 or Rb was required: shp53 alone or E7 alone did not prevent Ras-induced mitochondrial mass/ROS, E7 partially reduced them, and shp53 plus E7 prevented ROS, mitochondrial mass, and senescence; shp16 with shp53 also prevented these changes, and E1A inhibited Ras-dependent mitochondrial mass/ROS.
- Direct mitochondrial dysfunction triggered senescence: RISP knockdown caused growth arrest by 6 days with SA-β-Gal, G1 arrest, low BrdU, DNA damage foci, PML bodies, hypophosphorylated Rb, low Mcm6, p21/HDM2 induction, increased ROS/mtDNA, decreased ATP, and AMPK activation; rotenone and oligomycin inhibited growth, with rotenone more efficient at inducing SA-β-Gal, PML bodies, superoxide, and mitochondrial mass.
Methods
- Normal human diploid IMR90 fibroblasts were infected with retroviral Ha-RasV12 or controls, selected with puromycin, and analyzed at 2 days and 8 days after selection; additional experiments used shRNAs against p53, p16, or RISP, E7, E1A, rotenone, and oligomycin.
- Assays included qPCR for mtDNA/nuDNA and gene expression; FACS and immunofluorescence for MitoFluor Green, JC-1, MitoSox, DHE, DCFDA, BrdU/PI, SA-β-gal, 8-OHdG, γH2AX, PML, and catalase; Western blotting for AMPK, phospho-AMPK, ACC, p53, p21, HDM2, Ras, Rb, RISP, and tubulin; plus ATP and glucose-consumption measurements.
- Main analysis compared Ras-expressing versus control cells at pre-senescent and senescent time points, tested p53/Rb pathway requirements, and tested sufficiency of mitochondrial dysfunction via RISP knockdown and mitochondrial inhibitors.
Limitations
- Stated: the authors cannot eliminate possible contributions of increased cellular ATPase activities or metabolic futile cycles to the ATP drop; the identity and role of perinuclear vacuoles remain to be investigated; it remains challenging to determine whether superoxide production or loss of membrane potential comes first; more studies are required to link p53 and Rb to mitochondria during OIS; further studies are needed for tumor-selective mitochondrial strategies.
- Stated: antioxidant treatment retarded but did not completely prevent OIS (data not shown).
- Evident from the text: findings are largely in one normal human fibroblast line (IMR90) with retroviral RasV12, with no in vivo tumor model; several conclusions rely on pharmacological inhibitors and shRNA, and some supporting results are in supplemental figures or not shown.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
23 Valid · 1 Not valid · 13 Not checked · 95 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“It has been demonstrated that mitochondria play a critical role in replicative senescence, and several mitochondrial changes, including an increase in the production of reactive oxygen species (ROS), were reported in cells with short telomeres (34, 35).”
What the sources say
- Supportedcites [34] source
The Introduction links short telomere length with mitochondrial dysfunction in senescent-phenotype fibroblasts. The Results section “Mitochondrial Dysfunction in Senescent Fibroblasts” reports increased mitochondrial superoxide and other mitochondrial changes, including reduced membrane potential and increased mitochondrial mass. No page numbers are available in our copy. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [35] source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“OIS is phenotypically similar to the senescence response triggered by short telomeres, also known as replicative senescence (6).”
What the sources say
- Supportedcites [6] source
The paper describes dysfunctional telomeres and overexpressed oncogenes as distinct triggers of the same cellular senescence response (Abstract; Good Citizens—Cells Senesce in Response to Potential Cancer-Causing Events, page unavailable). It also identifies telomere-shortening-induced arrest as replicative senescence. This supports the broad claim of phenotypic similarity, though the passages do not compare individual phenotypic features. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In turn, the loss of membrane potential may increase ROS production (4).”
What the sources say
- Partly supportedcites [4] sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) reports that PTP opening, which uncouples mitochondria, increased H₂O₂ production when NADH was supplied. It also reports that PTP opening inhibited H₂O₂ production without that supply, while uncoupling has been shown to decrease ROS. The paper attributes the increase to a change in complex I, not to loss of membrane potential itself. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“It has been demonstrated that mitochondria play a critical role in replicative senescence, and several mitochondrial changes, including an increase in the production of reactive oxygen species (ROS), were reported in cells with short telomeres (34, 35).”
What the sources say
- Supportedcites [34] source
The Introduction reports that reducing mitochondrial superoxide generation delayed telomere damage and extended replicative lifespan. The Discussion concludes that mitochondrial ROS production is a determinant of telomere-dependent replicative senescence. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [35] source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“OIS also involves the DNA damage response (2, 15, 28), but the mechanism of DNA damage and the contribution of mitochondria to it are unclear.”
What the sources say
- Not checked — no full text of the sourcecites [2] source
- Not checked — no full text of the sourcecites [15] source
- Supportedcites [28] source
The section “STAT5A and RasV12 induce a constitutive activation of the DNA damage signaling pathway” reports DNA damage foci in cells induced to senesce by either oncogene. The “ODDI persist in cells that bypassed senescence” section also concludes that oncogenic activity activates the DNA damage signaling pathway, which supports the attributed claim. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
70 more claims · 4 with their cited sources checked
Create a free account to see all 132 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 38
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“sustained activation of 5′AMP-activated protein kinase (AMPK), a major bioenergetic sensor, is a hallmark of senescence (Moiseeva et al., 2009) and can induce a senescence arrest”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Moiseeva et al., 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ROS can damage DNA directly or through oxidative lesions that increase replication fork collapse by preventing its progression, thereby exacerbating the formation of DNA breaks and DDR activation [121,122].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the early stage of senescence, mitochondria do not function properly and display impaired oxidative phosphorylation capacity and reduced inner membrane potential, resulting in ROS overproduction [120,121,208,211].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [121]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Dysfunctional mitochondria can induce cellular senescence in culture (Moiseeva et al., 2009; Wang et al., 2003) and in vivo (Dai et al., 2010; Kang et al., 2013).”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Moiseeva et al., 2009
The cited source says what the claim attributes to it.
In the citing paper
“Mitochondrial ROS can damage nuclear DNA, thus activating a DNA damage response that induces senescence (Moiseeva et al., 2009; Passos et al., 2010).”
From Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype (2016) · cites this paper as Moiseeva et al., 2009
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 8×
“Ras-induced senescence in human cells can be mediated by either the p53 or the Rb family of tumor suppressors (28, 29, 43, 48).”
BackgroundInfluentialA DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917 · cited 1×
“Replicative senescence is, in essence, the consequence of a DNA damage response triggered by short telomeres (11).”
BackgroundDNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“Thus, we used an shRNA against p16INK4 (32) alone or in combination with shp53 to evaluate the roles of the p16/Rb and p53 pathways in the mitochondrial changes induced by oncogenic ras.”
MethodActivation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Mitochondria: Dynamic Organelles in Disease, Aging, and Development
Chan, D. C. (2006) · Cell · doi:10.1016/j.cell.2006.06.010 · Cited by 1,987
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · cited 1×
“In particular, E1A inhibits p53 phosphorylation at serine 15 (14), a hallmark of the activation of the DNA damage response during senescence (3, 12).”
Background
Cited by
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
Self-citationThe essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
“It is widely assumed that not oxygen itself, but rather ROS produced by mitochondria are involved in senescence (Lu and Finkel 2008; Moiseeva et al. 2009).”
BackgroundMitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype
Wiley, C. D., Velarde, M. C., Lecot, P., Liu, S., Sarnoski, E. A., Freund, A., Shirakawa, K., Lim, H. W., Davis, S. S., Ramanathan, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.011 · Cited by 1,275
“Dysfunctional mitochondria can induce cellular senescence in culture (Moiseeva et al., 2009; Wang et al., 2003) and in vivo (Dai et al.”
BackgroundInfluentialCellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“IFN can also induce senescence by triggering DNA damage in the target cells (232, 312).”
BackgroundMitochondrial dysfunction in cell senescence and aging
Miwa, S., Kashyap, S., Chini, E., & von Zglinicki, T. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158447 · Cited by 1,061
“The same type of mitochondrial dysfunction was also found in oncogene- (RAS-)induced senescence (69).”
Background
Metadata
- Authors
- Moiseeva, O., Bourdeau, V., Roux, A., Deschênes-Simard, X., & Ferbeyre, G.
- Affiliations
- Université de Montréal (CA)
- Département de Biochimie, Université de Montréal, C.P. 6128, Succ. Centre-Ville, Montréal, Québec H3C 3J7, Canada
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2009-08-01
- Volume
- 29
- Issue
- 16
- Pages
- 4495-4507
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2725737
- OpenAlex
- W2007244362
- Semantic Scholar
- 0f205d3fb7be9572b5161598c2febdb513a25421
- Cited by
- 408
- References
- 52
- Citations by year
- 2026: 15 · 2025: 27 · 2024: 28 · 2023: 32 · 2022: 29 · 2021: 28 · 2020: 36 · 2019: 28 · 2018: 25 · 2017: 22 · 2016: 25 · 2015: 16 · 2014: 25 · 2013: 12 · 2012: 22
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- oncogene-induced senescence, mitochondrial dysfunction, oncogenic Ras, reactive oxygen species, mitochondrial DNA, oxidative DNA damage, AMPK activation, p53, Rieske iron-sulfur protein, electron transport inhibition, oxidative phosphorylation, ATP depletion, mitochondrial mass
- MeSH terms
- Adenylate Kinase, Animals, Cell Cycle, Cell Line, DNA Damage, Enzyme Activation, Humans, Mitochondria, Genes, ras, Electron Transport Complex III, Cellular Senescence, Reactive Oxygen Species, Oxidative Stress, ras Proteins, Gene Expression Profiling, Genes, Mitochondrial, Membrane Potential, Mitochondrial
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence. https://app.cochat.ai/papers/10.1128/mcb.01868-08
- The paper
- Moiseeva, O., Bourdeau, V., Roux, A., Deschênes-Simard, X., & Ferbeyre, G. (2009). Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence. Molecular and Cellular Biology. https://doi.org/10.1128/mcb.01868-08
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.